small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 71 results

Industry

Insurance

Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities....Read more

Practice Area

Insurance Litigation

For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Experience 42 results

Experience

|

January 5, 2026

Winston advised ODDO BHF “Strategic Opportunities” on its investment in Groupe Hueber Assurances

Winston & Strawn LLP Paris advised ODDO BHF “Strategic Opportunities” on its investment in Groupe Hueber Assurances, a leading player in digital insurance brokerage, notably in health and pet insurance....Read more

Experience

|

June 12, 2025

Winston Serves as Lead Counsel to GCP Capital Partners in New Continuation Vehicle

Winston & Strawn served as legal counsel to GCP Capital Partners (GCP) in connection with the formation and closing of a single-asset continuation vehicle involving ALKEME Insurance. Led by the PE and Funds Group practices, the team advised GCP throughout the transaction which included substantial newly committed capital to fund portfolio company ALKEME’s continued growth (the single asset). The fund raise was backed by a syndicate of institutional investors where Apollo S3 served as the lead investor. The deal signals a growing trend: the strategic use of continuation vehicles to extend sponsors’ ownership in high-performing portfolio companies. This deal also reflects a broader narrative in middle-market private equity: firms that started small are now scaling rapidly, and they’re turning to sophisticated liquidity solutions to fuel that growth....Read more

Experience

|

April 23, 2025

Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination

Winston & Strawn represented Voyager Acquisition Corp. in its announced business combination agreement with VERAXA Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies. The combination will result in VERAXA becoming a publicly traded company on Nasdaq under the ticker symbol “VERX”, with a pre-money equity valuation of $1.3 billion and up to $253 million in cash held in trust by Voyager. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory and shareholder approvals....Read more
View All Experience

Insights & News 1,632 results

Life at Winston

|

April 22, 2026

|

1 Min Read

Winston For Good Heroes: Martha Huffman is a Beneficent Beekeeper, Community Member & Colleague

Giving back to Fate, Texas—the small community where she has lived on her “ranchette” for the past 28 years—is a way of life for Martha. Beekeeping and local politics are simply the latest ways in which she pays her good fortune forward within Fate.

Product Liability & Mass Torts Digest

|

April 3, 2026

|

8 Min Read

A Recipe for Exclusion: Why the Baby Food MDL Experts Failed Under Daubert

In a high-stakes decision on expert exclusion authored late last month, the District Court for the Northern District of California granted defendants’ motion to exclude plaintiffs’ general causation expert witnesses in In re Baby Food Products Liability Litigation—a consolidated mass tort of over 100 pending cases regarding the alleged presence of toxic heavy metals in baby food.

Recognitions

|

March 31, 2026

|

Less Than 1 Min Read

Winston Paris Teams Recognized in Three Categories During the 2026 Palmarès du Droit Awards

Organized in partnership with Le Monde du Droit, the Palmarès du Droit award ceremony was held on March 31, 2026. The ceremony honors the top business law firms based on client votes only....Read more
View All Insights & News

Other Results 53 results

Site Content

Attorney Work-Life Integration

Site Content

What Is Healthcare Privacy Law?

Today, healthcare privacy law is driven by the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This federal privacy rule establishes protections for specific patient health information. Healthcare plans, clearinghouses, and providers are subject to the law....Read more

Site Content

Who Are Institutional Investors?

Institutional investors are large non-individual shareholders, including hedge funds, pension funds, mutual funds, endowment funds, and insurance companies....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising